almagate has been researched along with Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrlich, R; Harris, A; Hussain, RM; Prall, R; Siesky, B; Yung, CW | 1 |
| Duan, X; Jia, X | 1 |
| Gelisken, F; Ziemssen, F | 1 |
1 review(s) available for almagate and Ischemia
| Article | Year |
|---|---|
[Diabetic maculopathy. Diagnosis and treatment].
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glycated Hemoglobin; Humans; Intravitreal Injections; Ischemia; Laser Coagulation; Macular Edema; Ophthalmoscopy; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
2 other study(ies) available for almagate and Ischemia
| Article | Year |
|---|---|
The effect of pegaptanib (Macugen(®) ) injection on retinal and retrobulbar blood flow in retinal Ischaemic diseases.
Topics: Adult; Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Blood Flow Velocity; Diabetic Retinopathy; Female; Humans; Injections, Intraocular; Ischemia; Laser-Doppler Flowmetry; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Artery; Retinal Vein Occlusion; Ultrasonography, Doppler, Color; Vascular Endothelial Growth Factor A | 2015 |
[Application of anti-VEGF agents in treatment of neovascular glaucoma and anti-scarring in filtering surgery].
Topics: Aptamers, Nucleotide; Bevacizumab; Cicatrix; Filtering Surgery; Glaucoma, Neovascular; Humans; Ischemia; Ranibizumab; Retinal Vessels; Vascular Endothelial Growth Factor A | 2015 |